Holoclara Inc.
PrivateLast Round
Series A
Jun 27, 2024
Total Funding Raised
$16.26M
Company Overview
Holoclara Inc. is a biotechnology company that develops orally available, symbiont-derived immunotherapies for autoimmune and allergic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
biotechnologysmall molecule therapeuticsdrug discoveryimmunomodulatoryautoimmune diseaseeosinophilic esophagitisinflammatory bowel diseaseIBDclinical trialsdrug developmentbiotech startupAI drug discoverymulti-omicsnematode-derived therapeuticsworm-derived medicine
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Holoclara Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Holoclara Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 27, 2024 | ||||
| Grant | Apr 15, 2023 | ||||
| Seed | May 9, 2017 |
Holoclara Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A |
| NIH RADx | Grant |
| Freeflow Ventures | Series A |
| Kairos Ventures | Seed |
| BOLD Capital Partners | Series A |
| SV Latam Capital | Series A |
| National Heart, Lung, and Blood Institute | Grant |
Holoclara Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Holoclara Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersPasadena, California
Employee Range7
Year Founded2017
Last FundingJun 27, 2024